Abstract
The prediction of drug metabolism is an important task in drug development. Besides well-established in vitro and in vivo methods using biological matrices, several biomimetic models have been developed. This review summarizes three different nonenzymatic strategies, including metalloporphyrins as surrogates of the active centre of cytochrome P450, Fenton’s reagent, and the electrochemical oxidation of drug compounds. Although none of the systems can simulate the whole range of cytochrome P450-catalyzed reactions adequately, the biomimetic models show some advantages over standard in vitro methods. For example, metalloporpyhrin catalysts allow the synthesis of certain metabolites in sufficient amounts and with sufficient purities to permit characterization and further pharmacological and toxicological tests. The electrochemical generation of metabolites coupled on-line to liquid chromatography/mass spectrometry is a promising tool for studying reactive metabolites and can be applied in automated high-throughput screening approaches. In this paper, detailed comparisons with cytochrome P450 catalysis are drawn, advantages and disadvantages of the respective methods are revealed, and possible applications are discussed.
Similar content being viewed by others
References
Meunier B, Bernadou J (2000) Struct Bonding 97:1–35
Sono M, Roach MP, Coulter ED, Dawson JH (1996) Chem Rev 96:2841–2887
Brandon EFA, Raap CD, Meijerman I, Beijnen JH, Schellens JHM (2003) Toxicol Appl Pharmacol 189:233–246
Pelkonen O, Turpeinen M, Uusitalo J, Rautio A, Raunio H (2005) Basic Clin Pharmacol Toxicol 96:167–175
Plant N (2004) Drug Discovery Today 9:328–336
Groves JT, Nemo TE, Myers RS (1979) J Am Chem Soc 101:1032–1033
Traylor PS, Dolphin D, Traylor TG (1984) J Chem Soc Chem Commun 279–280
Bernadou J, Meunier B (2004) Adv Synth Catal 346:171–184
Feiters MC, Rowan AE, Nolte RJM (2000) Chem Soc Rev 29:375–384
Meunier B (1992) Chem Rev 92:1411–1456
Meunier B, de Visser SP, Shaik S (2004) Chem Rev 104:3947–3980
Vicente MGH, Smith KM (2000) Curr Org Chem 4:139–174
Nagatsu Y, Higuchi T, Hirobe M (1990) Chem Pharm Bull 38:400–403
Chauhan SMS, Kandadai SA, Sahoo B (2001) Chem Pharm Bull 49:1375–1376
Melo AJB, Iamamoto Y, Maestrin APJ, Lindsay-Smith JR, Santos MD, Lopes NP, Bonato PS (2005) J Mol Catal A 226:23–31
Meier H, Blaschke G (2001) J Pharm Biomed Anal 26:409–415
Chorghade MS, Dezaro DA, Hill DR, Lee EC, Pariza RJ, Andersen JV, Hansen KT, Dolphin DH (1994) Bioorg Med Chem Lett 4:2867–2870
Chorghade MS, Hill DR, Lee EC, Pariza RJ, Dolphin DH, Hino F, Zhang LY (1996) Pure Appl Chem 68:753–756
Ferrero JL, Thomas SB, Marsh KC, Rodrigues D, Uchic JT, Buko AM (2002) Drug Metab Dispos 30:1094–1101
Mansuy D, Battioni P, Battioni JP (1989) Eur J Biochem 184:267–285
Mansuy D (1990) Pure Appl Chem 62:741–746
Dansette PM, Amar C, Valadon P, Pons C, Beaune PH, Mansuy D (1991) Biochem Pharmacol 41:553–560
Mori Y, Kuroda N, Sakai Y, Yokoya F, Toyoshi K, Baba S (1985) Drug Metab Dispos 13:239–245
Othman S, Mansuy-Mouries V, Bensoussan C, Battioni P, Mansuy D (2000) C R Acad Sci Paris Sér IIc 3:751–755
Poon GK, Chen Q, Teffera Y, Ngui JS, Griffin PR, Braun MP, Doss GA, Freeden C, Stearns RA, Evans DC, Baillie TA, Tang W (2001) Drug Metab Dispos 29:1608–1613
Spasojević I, Colvin OM, Warshany KR, Batinić-Haberle I (2006) J Inorg Biochem 100:1897–1902
Brock N (1996) Cancer 78:542–547
Oda Y, Imaoka S, Nakahira Y, Asada A, Fujimori M, Fujita S, Funae Y (1989) Biochem Pharmacol 38:4439–4444
Carrier MN, Battioni P, Mansuy D (1993) Bull Soc Chim Fr 130:405–416
Chorghade MS, Hill DR, Lee EC, Pariza RJ (1996) Pure Appl Chem 68:753–756
Angundez JAG, Martinez C, Benitez J (1995) Xenobiotica 25:417–427
Hill DR, Celebuski JE, Pariza RJ, Chorghade MS, Levenberg M, Pagano T, Cleary G, West P, Whittern D (1996) Tetrahedron Lett 37:787–790
Rodrigues AD, Roberts EM, Mulford DJ, Yao Y, Ouellet D (1997) Drug Metab Dispos 25:623–630
Maurin AJM, Ianamoto Y, Lopes NP, Lindsay-Smith JR, Bonato PS (2003) J Braz Chem Soc 14:322–328
Smolinka K, Göber B (1999) Eur J Org Chem 679–683
Andersen JV, Hansen KT (1997) Xenobiotica 27:901–912
Sotelo J, Jung H (1998) Clin Pharmacokinet 34:503–515
Bernadou J, Fabiano AS, Robert A, Meunier B (1994) J Am Chem Soc 116:9375–9376
Yang SJ, Nam W (1998) Inorg Chem 37:606–607
Lertratanangkoon K, Horning MG (1982) Drug Metab Dispos 10:1–10
Bernadou J, Bonnafous M, Labat G, Loiseau P, Meunier B (1991) Drug Metab Dispos 19:360–364
Vidal M, Bonnafous M, Defrance S, Loiseau P, Bernadou J, Meunier B (1993) Drug Metab Dispos 21:811–817
Masumoto H, Takeuchi K, Ohta S, Hirobe M (1989) Chem Pharm Bull 37:1788–1794
Balahura RJ, Sorokin A, Bernadou J, Meunier B (1997) Inorg Chem 36:3488–3492
Alkatheeri NA, Wasfi IA, Lambert M (1999) J Vet Pharmacol Therap 22:127–135
Miyachi H, Nagatsu Y (2002) Chem Pharm Bull 50:1137–1140
Ohmori S, Miura M, Toriumi C, Satoh Y, Ooie T (2007) Drug Metab Dispos 35:1624–1633
Collman JP, Brauman JI, Meunier B, Hayashi T, Kodadek T, Raybuck SA (1985) J Am Chem Soc 107:2000–2005
Mansuy D, Battioni P, Renaud JP (1984) J Chem Soc Chem Commun 1255–1257
Chauhan SMS, Sahoo BB (1999) Bioorg Med Chem 7:2629–2634
Hamman MA, Thompson GA, Hall SD (1997) Biochem Pharmacol 54:33–41
Doi T, Mori T, Mashino T, Hirobe M (1993) Biochem Biophys Res Commun 191:737–743
Goldstein S, Meyerstein D, Czapski G (1993) Free Radic Biol Med 15:135–445
Fenton HJH (1894) J Chem Soc 65:899–910
Van der Steen J, Timmer EC, Westra JG, Benckhuysen C (1973) J Am Chem Soc 95:7525–7536
Zbaida S, Kariv R, Fischer P, Silman-Greespan J, Tashima Z (1986) Eur J Biochem 154:603–605
Zbaida S, Kariv R, Fischer P, Gilhar D (1987) Xenobiotica 17:617–621
Oturan MA, Pinson J, Oturan N, Deprez D (1999) New J Chem 23:793–794
Jurva U, Wikström HV, Bruins AP (2002) Rapid Commun Mass Spectrom 16:1934–1940
Johansson T, Weidolf L, Jurva U (2007) Rapid Commun Mass Spectrom 21:2323–2331
Shono T, Toda T, Oshino N (1981) Drug Metab Dispos 9:481–482
Shono T, Toda T, Oshino N (1982) J Am Chem Soc 104:2639–2641
Macdonald TL, Gutheim WG, Martin RB, Guengerich FP (1989) Biochemistry 28:2071–2077
Hall LR, Iwamoto RT, Hanzlik RP (1989) J Org Chem 54:2446–2451
Hall LR, Hanzlik RP (1990) J Biol Chem 265:12349–12355
Zhang F, Dryhurst G (1995) J Electroanal Chem 398:117–128
Xu R, Huang X, Kramer KJ, Hawley MD (1996) Bioorg Chem 24:110–126
Paci A, Martens T, Royer J (2001) Bioorg Med Chem Lett 11:1347–1349
Galvão de Lima R, Sueli Bonato P, Santana da Silva R (2003) J Pharm Biomed Anal 32:337–343
Hambitzer G, Heitbaum J (1986) Anal Chem 58:1067–1070
Volk KJ, Lee MS, Yost RA, Brajter-Toth A (1986) Anal Chem 60:720–722
Volk KJ, Yost RA, Brajter-Toth A (1989) J Chromatogr A 474:231–243
Volk KJ, Yost A, Brajter-Toth A (1989) Anal Chem 61:1709–1717
Volk KJ, Yost RA, Brajter-Toth A (1990) J Electrochem Soc 137:1764–1771
Regino MCS, Brajter-Toth A (1997) Anal Chem 69:5067–5072
Zhou F, Van Berkel GJ (1995) Anal Chem 67:3643–3649
Xu X, Lu W, Cole RB (1996) Anal Chem 68:4244–4253
Cole RB, Xu X (1999) US Patent 5 879 949
Lu W, Xu X, Cole RB (1997) Anal Chem 69:2478–2484
Arakawa R, Abura T, Fukuo T, Horiguchi H, Matsubayashi G (1999) Bull Chem Soc Jpn 72:1519–1523
Deng H, Van Berkel GJ (1999) Anal Chem 71:4284–4293
Kertesz V, Van Berkel GJ (2001) Electroanal 13:1425–1430
Kertesz V, Deng H, Asano KG, Hettich RL, Van Berkel GJ (2002) Electroanalysis 14:1027–1030
Hayen H, Karst U (2003) Anal Chem 75:4833–4840
Seiwert B, Henneken H, Karst U (2004) J Am Chem Soc Mass Spectrom 15:1727–1736
Seiwert B, Karst U (2007) Anal Bioanal Chem 388:1633–1642
Permentier HP, Jurva U, Barroso B, Bruins AP (2003) Rapid Commun Mass Spectrom 17:1585–1592
Diehl G, Karst U (2002) Anal Bioanal Chem 373:390–398
Karst U (2004) Angew Chem Int Ed 43:2476–2478
Van Berkel GJ, McLuckey SA, Glish GL (1991) Anal Chem 63:1098–1109
Blades T, Ikonomou MG, Kebarle P (1991) Anal Chem 63:2109–2114
Van Berkel GJ, McLuckey SA, Glish GL (1992) Anal Chem 64:1586–1593
Van Berkel GJ, Zhou F (1995) Anal Chem 67:2916–2923
Van Berkel GJ, Zhou F (1995) Anal Chem 67:3658–3964
Van Berkel GJ (2000) J Am Soc Mass Spectrom 11:951–960
Kertesz V, Van Berkel GJ (2001) J Mass Spectrom 36:204–210
Van Berkel GJ, Kertesz V (2001) J Mass Spectrom 36:1125–1132
Van Berkel GJ, Asano KG, Kertesz V (2002) Anal Chem 74:5047–5056
Van Berkel GJ (2003) US Patent 6 784 439
Van Berkel GJ (2004) US Patent 6 677 593
Van Berkel GJ, Kertesz V, Ford MJ, Granger MC (2004) J Am Soc Mass Spectrom 15:1755–1766
Van Berkel GJ, Kertesz V (2005) Anal Chem 77:8041–8049
Kertesz V, Van Berkel GJ (2006) J Am Soc Mass Spectrom 17:953–961
Van Berkel GJ, Kertesz V (2007) Anal Chem 79:5510–5520
Svendsen CN (1993) Analyst 118:123–129
Özkan SA (2007) Chromatographia 66:S3–S13
Getek TA, Korfmacher WA, McRae TA, Hinson JA (1989) J Chromatogr A 474:245–256
Deng H, Van Berkel GJ (1999) Electroanalysis 11:857–865
Iwahashi H (1999) J Chromatogr B 736:237–245
Jurva U, Wikström HV, Bruins AP (2000) Rapid Commun Mass Spectrom 14:529–533
Jurva U, Wikström HV, Weidolf L, Bruins AP (2003) Rapid Commun Mass Spectrom 17:800–810
Gamache PH, Smith R, McCarthy R, Waraska J, Acworth IN (2003) Spectroscopy 18:14–41
Gamache PH, Meyer DF, Granger MC, Acworth IN (2004) J Am Chem Mass Spectrom 15:1717–1726
Jurva U, Bissel P, Isin EM, Igarashi K, Kuttab S, Castagnoli N (2005) J Am Chem Soc 127:12368–12377
Nozaki K, Kitagawa H, Kimura S, Kagayama, Arakawa R (2006) J Mass Spectrom 41:606–612
Iwahashi H, Ishii T (1997) J Chromatogr A 773:23–31
Van Leeuwen SM, Blankert B, Kauffmann JM, Karst U (2005) Anal Bioanal Chem 382:742–750
Lohmann W, Karst U (2006) Anal Bioanal Chem 386:1701–1708
Yan Z, Caldwell GW (2004) Anal Chem 76:6835–6847
Madsen KG, Olsen J, Skonberg C, Hansen SH, Jurva U (2007) Chem Res Toxicol 20:821–831
Lohmann W, Karst U (2007) Anal Chem 79:6831–6839
Tahara K, Yano Y, Kanagawa K, Abe Y, Yamada J, Iijima S, Mochizuki M, Nishikawa T (2007) Chem Pharm Bull 55:1207–1212
He K, Woolf KF, Kindt EK, Fielder AE, Talaat RE (2001) Biochem Pharmacol 62:191–198
Biesaga M, Pyrzyńska K, Trojanowicz M (2000) Talanta 51:209–224
Acknowledgement
Financial support by the Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany) and the Fonds der Chemischen Industrie (Frankfurt/Main, Germany) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lohmann, W., Karst, U. Biomimetic modeling of oxidative drug metabolism. Anal Bioanal Chem 391, 79–96 (2008). https://doi.org/10.1007/s00216-007-1794-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-007-1794-x